A Case of Immune Thrombocytopenia Occurring after Radiotherapy plus Atezolizumab Treatment for Bladder Cancer

An 84-year-old female developed gross hematuria. She was diagnosed as urinary bladder carcinoma. She was initiated on concurrent atezolizumab plus radiation(a phase Ⅱ clinical trial)(jRCT2031180060). After 8 cycles of atezolizumab, complete response was confirmed. Maintenance atezolizumab treatment was started. Platelet(Plt)count decreased, there was no rechallenge with atezolizumab. Bone marrow examination revealed normal. Plt count recovered. Plt count decreased again. The serum levels of interleukin-6(IL-6)were elevated. She was diagnosed as having immune thrombocytopenia. She was started on treatment with prednisolone(PSL)at dose of 20 mg/day. Plt count was increased.

Medienart:

Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:50

Enthalten in:

Gan to kagaku ryoho. Cancer & chemotherapy - 50(2023), 9 vom: 28. Sept., Seite 985-992

Sprache:

Englisch

Beteiligte Personen:

Sekiguchi, Yasunobu [VerfasserIn]
Nishimura, You [VerfasserIn]
Kanda, Hiroaki [VerfasserIn]
Kawamura, Machiko [VerfasserIn]
Kobayashi, Kazuhiko [VerfasserIn]
Mitani, Koki [VerfasserIn]
Kurashina, Ryo [VerfasserIn]
Ikeda, Riko [VerfasserIn]
Inoue, Masaharu [VerfasserIn]
Matsuoka, Yoh [VerfasserIn]
Kageyama, Yukio [VerfasserIn]
Akaba, Yuki [VerfasserIn]
Kobayashi, Hirofumi [VerfasserIn]

Themen:

52CMI0WC3Y
Antibodies, Monoclonal, Humanized
Atezolizumab
Case Reports
Journal Article

Anmerkungen:

Date Completed 23.10.2023

Date Revised 23.10.2023

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362939306